Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

REG-Acquisition of Own Shares

$LKFTPress releaseSep 8, 2026, 4:02 PM ETRead the release

Lakefront Biotherapeutics repurchased 132,014 shares between August 31 and September 4, 2026, at an average price of €24.84 per share. The total value of the repurchases was €3.28 million, with the highest price paid reaching €25.38 per share.

Key figures

Shares Held
1293338
Average Price Paid
24.84
Shares Repurchased
132014

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    LKFT: REG-Acquisition of Own Shares — AI Analysis | Signal8